Shats I - Search Results

1

p53 plays a role in mesenchymal differentiation programs, in a cell fate dependent manner.

Molchadsky A, Shats I, Goldfinger N, Pevsner-Fischer M, Olson M, Rinon A, Tzahor E, Lozano G, Zipori D, Sarig R, Rotter V. Molchadsky A, et al. Among authors: shats i. PLoS One. 2008;3(11):e3707. doi: 10.1371/journal.pone.0003707. Epub 2008 Nov 12. PLoS One. 2008. PMID: 19002260 Free PMC article.

2

p53 is a regulator of macrophage differentiation.

Matas D, Milyavsky M, Shats I, Nissim L, Goldfinger N, Rotter V. Matas D, et al. Among authors: shats i. Cell Death Differ. 2004 Apr;11(4):458-67. doi: 10.1038/sj.cdd.4401379. Cell Death Differ. 2004. PMID: 14713961

3

The murine telomerase catalytic subunit shares the PAb-240 mutant specific epitope of the p53 protein.

Shats I, Milyavsky M, Erez N, Rotter V. Shats I, et al. FEBS Lett. 2003 Jul 10;546(2-3):321-4. doi: 10.1016/s0014-5793(03)00607-0. FEBS Lett. 2003. PMID: 12832061 Free article.

4

Activated p53 suppresses the histone methyltransferase EZH2 gene.

Tang X, Milyavsky M, Shats I, Erez N, Goldfinger N, Rotter V. Tang X, et al. Among authors: shats i. Oncogene. 2004 Jul 29;23(34):5759-69. doi: 10.1038/sj.onc.1207706. Oncogene. 2004. PMID: 15208672

5

Transcriptional programs following genetic alterations in p53, INK4A, and H-Ras genes along defined stages of malignant transformation.

Milyavsky M, Tabach Y, Shats I, Erez N, Cohen Y, Tang X, Kalis M, Kogan I, Buganim Y, Goldfinger N, Ginsberg D, Harris CC, Domany E, Rotter V. Milyavsky M, et al. Among authors: shats i. Cancer Res. 2005 Jun 1;65(11):4530-43. doi: 10.1158/0008-5472.CAN-04-3880. Cancer Res. 2005. PMID: 15930270

6

hTERT-immortalized prostate epithelial and stromal-derived cells: an authentic in vitro model for differentiation and carcinogenesis.

Kogan I, Goldfinger N, Milyavsky M, Cohen M, Shats I, Dobler G, Klocker H, Wasylyk B, Voller M, Aalders T, Schalken JA, Oren M, Rotter V. Kogan I, et al. Among authors: shats i. Cancer Res. 2006 Apr 1;66(7):3531-40. doi: 10.1158/0008-5472.CAN-05-2183. Cancer Res. 2006. PMID: 16585177

7

Inactivation of myocardin and p16 during malignant transformation contributes to a differentiation defect.

Milyavsky M, Shats I, Cholostoy A, Brosh R, Buganim Y, Weisz L, Kogan I, Cohen M, Shatz M, Madar S, Kalo E, Goldfinger N, Yuan J, Ron S, MacKenzie K, Eden A, Rotter V. Milyavsky M, et al. Among authors: shats i. Cancer Cell. 2007 Feb;11(2):133-46. doi: 10.1016/j.ccr.2006.11.022. Cancer Cell. 2007. PMID: 17292825 Free article.

8

Myocardin in tumor suppression and myofibroblast differentiation.

Shats I, Milyavsky M, Cholostoy A, Brosh R, Rotter V. Shats I, et al. Cell Cycle. 2007 May 15;6(10):1141-6. doi: 10.4161/cc.6.10.4251. Epub 2007 May 9. Cell Cycle. 2007. PMID: 17495540 Review.

9

Activation of p53 protein by telomeric (TTAGGG)n repeats.

Milyavsky M, Mimran A, Senderovich S, Zurer I, Erez N, Shats I, Goldfinger N, Cohen I, Rotter V. Milyavsky M, et al. Among authors: shats i. Nucleic Acids Res. 2001 Dec 15;29(24):5207-15. doi: 10.1093/nar/29.24.5207. Nucleic Acids Res. 2001. PMID: 11812854 Free PMC article.

10

Regulation of AIF expression by p53.

Stambolsky P, Weisz L, Shats I, Klein Y, Goldfinger N, Oren M, Rotter V. Stambolsky P, et al. Among authors: shats i. Cell Death Differ. 2006 Dec;13(12):2140-9. doi: 10.1038/sj.cdd.4401965. Epub 2006 May 26. Cell Death Differ. 2006. PMID: 16729031

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

43 results

Search Page

Filters